{
  "id": "https://openalex.org/W2166751652",
  "doi": "https://doi.org/10.1517/13543784.12.12.1963",
  "title": "The role of mineralocorticoid receptor antagonists in the treatment of cardiac failure",
  "display_name": "The role of mineralocorticoid receptor antagonists in the treatment of cardiac failure",
  "publication_year": 2003,
  "publication_date": "2003-12-01",
  "ids": {
    "openalex": "https://openalex.org/W2166751652",
    "doi": "https://doi.org/10.1517/13543784.12.12.1963",
    "mag": "2166751652",
    "pmid": "https://pubmed.ncbi.nlm.nih.gov/14640940"
  },
  "language": "en",
  "primary_location": {
    "is_oa": false,
    "landing_page_url": "https://doi.org/10.1517/13543784.12.12.1963",
    "pdf_url": null,
    "source": {
      "id": "https://openalex.org/S131064935",
      "display_name": "Expert Opinion on Investigational Drugs",
      "issn_l": "1354-3784",
      "issn": [
        "1354-3784",
        "1744-7658"
      ],
      "is_oa": false,
      "is_in_doaj": false,
      "is_indexed_in_scopus": true,
      "is_core": true,
      "host_organization": "https://openalex.org/P4310320547",
      "host_organization_name": "Taylor & Francis",
      "host_organization_lineage": [
        "https://openalex.org/P4310320547"
      ],
      "host_organization_lineage_names": [
        "Taylor & Francis"
      ],
      "type": "journal"
    },
    "license": null,
    "license_id": null,
    "version": null,
    "is_accepted": false,
    "is_published": false
  },
  "type": "review",
  "type_crossref": "journal-article",
  "indexed_in": [
    "crossref",
    "pubmed"
  ],
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "authorships": [
    {
      "author_position": "first",
      "author": {
        "id": "https://openalex.org/A5019746134",
        "display_name": "John W. Funder",
        "orcid": "https://orcid.org/0000-0001-7733-7005"
      },
      "institutions": [
        {
          "id": "https://openalex.org/I60733029",
          "display_name": "Monash Institute of Medical Research",
          "ror": "https://ror.org/05p96ba03",
          "country_code": "AU",
          "type": "healthcare",
          "lineage": [
            "https://openalex.org/I60733029"
          ]
        }
      ],
      "countries": [
        "AU"
      ],
      "is_corresponding": true,
      "raw_author_name": "John W Funder",
      "raw_affiliation_strings": [
        "Prince Henry's Institute of Medical Research, PO Box 5152, Clayton 3168, Victoria, Australia"
      ],
      "affiliations": [
        {
          "raw_affiliation_string": "Prince Henry's Institute of Medical Research, PO Box 5152, Clayton 3168, Victoria, Australia",
          "institution_ids": [
            "https://openalex.org/I60733029"
          ]
        }
      ]
    }
  ],
  "institution_assertions": [],
  "countries_distinct_count": 1,
  "institutions_distinct_count": 1,
  "corresponding_author_ids": [
    "https://openalex.org/A5019746134"
  ],
  "corresponding_institution_ids": [
    "https://openalex.org/I60733029"
  ],
  "apc_list": null,
  "apc_paid": null,
  "fwci": 0.405,
  "has_fulltext": true,
  "fulltext_origin": "ngrams",
  "cited_by_count": 12,
  "citation_normalized_percentile": {
    "value": 0.235193,
    "is_in_top_1_percent": false,
    "is_in_top_10_percent": false
  },
  "cited_by_percentile_year": {
    "min": 81,
    "max": 82
  },
  "biblio": {
    "volume": "12",
    "issue": "12",
    "first_page": "1963",
    "last_page": "1969"
  },
  "is_retracted": false,
  "is_paratext": false,
  "primary_topic": {
    "id": "https://openalex.org/T11839",
    "display_name": "Hormonal Regulation and Hypertension",
    "score": 1.0,
    "subfield": {
      "id": "https://openalex.org/subfields/2712",
      "display_name": "Endocrinology, Diabetes and Metabolism"
    },
    "field": {
      "id": "https://openalex.org/fields/27",
      "display_name": "Medicine"
    },
    "domain": {
      "id": "https://openalex.org/domains/4",
      "display_name": "Health Sciences"
    }
  },
  "topics": [
    {
      "id": "https://openalex.org/T11839",
      "display_name": "Hormonal Regulation and Hypertension",
      "score": 1.0,
      "subfield": {
        "id": "https://openalex.org/subfields/2712",
        "display_name": "Endocrinology, Diabetes and Metabolism"
      },
      "field": {
        "id": "https://openalex.org/fields/27",
        "display_name": "Medicine"
      },
      "domain": {
        "id": "https://openalex.org/domains/4",
        "display_name": "Health Sciences"
      }
    },
    {
      "id": "https://openalex.org/T14486",
      "display_name": "Cardiovascular, Neuropeptides, and Oxidative Stress Research",
      "score": 0.9956,
      "subfield": {
        "id": "https://openalex.org/subfields/2746",
        "display_name": "Surgery"
      },
      "field": {
        "id": "https://openalex.org/fields/27",
        "display_name": "Medicine"
      },
      "domain": {
        "id": "https://openalex.org/domains/4",
        "display_name": "Health Sciences"
      }
    },
    {
      "id": "https://openalex.org/T13012",
      "display_name": "Coenzyme Q10 studies and effects",
      "score": 0.9814,
      "subfield": {
        "id": "https://openalex.org/subfields/1312",
        "display_name": "Molecular Biology"
      },
      "field": {
        "id": "https://openalex.org/fields/13",
        "display_name": "Biochemistry, Genetics and Molecular Biology"
      },
      "domain": {
        "id": "https://openalex.org/domains/1",
        "display_name": "Life Sciences"
      }
    }
  ],
  "keywords": [
    {
      "id": "https://openalex.org/keywords/eplerenone",
      "display_name": "Eplerenone",
      "score": 0.94952106
    }
  ],
  "concepts": [
    {
      "id": "https://openalex.org/C2780072264",
      "wikidata": "https://www.wikidata.org/wiki/Q423804",
      "display_name": "Eplerenone",
      "level": 4,
      "score": 0.94952106
    },
    {
      "id": "https://openalex.org/C2776379505",
      "wikidata": "https://www.wikidata.org/wiki/Q422188",
      "display_name": "Spironolactone",
      "level": 3,
      "score": 0.86294085
    },
    {
      "id": "https://openalex.org/C71924100",
      "wikidata": "https://www.wikidata.org/wiki/Q11190",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.8442531
    },
    {
      "id": "https://openalex.org/C2778198053",
      "wikidata": "https://www.wikidata.org/wiki/Q181754",
      "display_name": "Heart failure",
      "level": 2,
      "score": 0.8029934
    },
    {
      "id": "https://openalex.org/C189135053",
      "wikidata": "https://www.wikidata.org/wiki/Q3454531",
      "display_name": "Mineralocorticoid receptor",
      "level": 3,
      "score": 0.7147243
    },
    {
      "id": "https://openalex.org/C177713679",
      "wikidata": "https://www.wikidata.org/wiki/Q679690",
      "display_name": "Intensive care medicine",
      "level": 1,
      "score": 0.54178107
    },
    {
      "id": "https://openalex.org/C2779343474",
      "wikidata": "https://www.wikidata.org/wiki/Q3109175",
      "display_name": "Context (archaeology)",
      "level": 2,
      "score": 0.52105516
    },
    {
      "id": "https://openalex.org/C535046627",
      "wikidata": "https://www.wikidata.org/wiki/Q30612",
      "display_name": "Clinical trial",
      "level": 2,
      "score": 0.47956413
    },
    {
      "id": "https://openalex.org/C126322002",
      "wikidata": "https://www.wikidata.org/wiki/Q11180",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.4748911
    },
    {
      "id": "https://openalex.org/C164705383",
      "wikidata": "https://www.wikidata.org/wiki/Q10379",
      "display_name": "Cardiology",
      "level": 1,
      "score": 0.45527452
    },
    {
      "id": "https://openalex.org/C2778525890",
      "wikidata": "https://www.wikidata.org/wiki/Q184564",
      "display_name": "Aldosterone",
      "level": 2,
      "score": 0.4405633
    },
    {
      "id": "https://openalex.org/C151730666",
      "wikidata": "https://www.wikidata.org/wiki/Q7205",
      "display_name": "Paleontology",
      "level": 1,
      "score": 0.0
    },
    {
      "id": "https://openalex.org/C86803240",
      "wikidata": "https://www.wikidata.org/wiki/Q420",
      "display_name": "Biology",
      "level": 0,
      "score": 0.0
    }
  ],
  "mesh": [
    {
      "descriptor_ui": "D006333",
      "descriptor_name": "Heart Failure",
      "qualifier_ui": "Q000188",
      "qualifier_name": "drug therapy",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D000451",
      "descriptor_name": "Mineralocorticoid Receptor Antagonists",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D013148",
      "descriptor_name": "Spironolactone",
      "qualifier_ui": "Q000031",
      "qualifier_name": "analogs & derivatives",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D042842",
      "descriptor_name": "11-beta-Hydroxysteroid Dehydrogenases",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D042842",
      "descriptor_name": "11-beta-Hydroxysteroid Dehydrogenases",
      "qualifier_ui": "Q000378",
      "qualifier_name": "metabolism",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000818",
      "descriptor_name": "Animals",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D002986",
      "descriptor_name": "Clinical Trials as Topic",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000077545",
      "descriptor_name": "Eplerenone",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D006333",
      "descriptor_name": "Heart Failure",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D006801",
      "descriptor_name": "Humans",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D006854",
      "descriptor_name": "Hydrocortisone",
      "qualifier_ui": "Q000502",
      "qualifier_name": "physiology",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D006854",
      "descriptor_name": "Hydrocortisone",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D006973",
      "descriptor_name": "Hypertension",
      "qualifier_ui": "Q000150",
      "qualifier_name": "complications",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D006973",
      "descriptor_name": "Hypertension",
      "qualifier_ui": "Q000503",
      "qualifier_name": "physiopathology",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D006973",
      "descriptor_name": "Hypertension",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D018161",
      "descriptor_name": "Receptors, Mineralocorticoid",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D018161",
      "descriptor_name": "Receptors, Mineralocorticoid",
      "qualifier_ui": "Q000187",
      "qualifier_name": "drug effects",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D013148",
      "descriptor_name": "Spironolactone",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D013148",
      "descriptor_name": "Spironolactone",
      "qualifier_ui": "Q000627",
      "qualifier_name": "therapeutic use",
      "is_major_topic": false
    }
  ],
  "locations_count": 2,
  "locations": [
    {
      "is_oa": false,
      "landing_page_url": "https://doi.org/10.1517/13543784.12.12.1963",
      "pdf_url": null,
      "source": {
        "id": "https://openalex.org/S131064935",
        "display_name": "Expert Opinion on Investigational Drugs",
        "issn_l": "1354-3784",
        "issn": [
          "1354-3784",
          "1744-7658"
        ],
        "is_oa": false,
        "is_in_doaj": false,
        "is_indexed_in_scopus": true,
        "is_core": true,
        "host_organization": "https://openalex.org/P4310320547",
        "host_organization_name": "Taylor & Francis",
        "host_organization_lineage": [
          "https://openalex.org/P4310320547"
        ],
        "host_organization_lineage_names": [
          "Taylor & Francis"
        ],
        "type": "journal"
      },
      "license": null,
      "license_id": null,
      "version": null,
      "is_accepted": false,
      "is_published": false
    },
    {
      "is_oa": false,
      "landing_page_url": "https://pubmed.ncbi.nlm.nih.gov/14640940",
      "pdf_url": null,
      "source": {
        "id": "https://openalex.org/S4306525036",
        "display_name": "PubMed",
        "issn_l": null,
        "issn": null,
        "is_oa": false,
        "is_in_doaj": false,
        "is_indexed_in_scopus": false,
        "is_core": false,
        "host_organization": "https://openalex.org/I1299303238",
        "host_organization_name": "National Institutes of Health",
        "host_organization_lineage": [
          "https://openalex.org/I1299303238"
        ],
        "host_organization_lineage_names": [
          "National Institutes of Health"
        ],
        "type": "repository"
      },
      "license": null,
      "license_id": null,
      "version": null,
      "is_accepted": false,
      "is_published": false
    }
  ],
  "best_oa_location": null,
  "sustainable_development_goals": [
    {
      "score": 0.85,
      "id": "https://metadata.un.org/sdg/3",
      "display_name": "Good health and well-being"
    }
  ],
  "grants": [],
  "datasets": [],
  "versions": [],
  "referenced_works_count": 25,
  "referenced_works": [
    "https://openalex.org/W1665675901",
    "https://openalex.org/W1966962224",
    "https://openalex.org/W1975618645",
    "https://openalex.org/W1990183776",
    "https://openalex.org/W1990427658",
    "https://openalex.org/W2006910397",
    "https://openalex.org/W2015497140",
    "https://openalex.org/W2019216135",
    "https://openalex.org/W2030980954",
    "https://openalex.org/W2031486533",
    "https://openalex.org/W2031752348",
    "https://openalex.org/W2037408526",
    "https://openalex.org/W2047109055",
    "https://openalex.org/W2047458689",
    "https://openalex.org/W2056893352",
    "https://openalex.org/W2060481021",
    "https://openalex.org/W2073261560",
    "https://openalex.org/W2106493153",
    "https://openalex.org/W2107307200",
    "https://openalex.org/W2108548563",
    "https://openalex.org/W2135106210",
    "https://openalex.org/W2136714451",
    "https://openalex.org/W2140323008",
    "https://openalex.org/W2148114970",
    "https://openalex.org/W2152094259"
  ],
  "related_works": [
    "https://openalex.org/W4232964041",
    "https://openalex.org/W2801040858",
    "https://openalex.org/W2320541894",
    "https://openalex.org/W2279875401",
    "https://openalex.org/W2271304487",
    "https://openalex.org/W2189187458",
    "https://openalex.org/W2009328678",
    "https://openalex.org/W2007204386",
    "https://openalex.org/W1979996291",
    "https://openalex.org/W1598280036"
  ],
  "abstract_inverted_index": {
    "AbstractIn": [
      0
    ],
    "most": [
      1
    ],
    "countries": [
      2
    ],
    "the": [
      3,
      14,
      66,
      76,
      101,
      138,
      147,
      161,
      168,
      171,
      185,
      195,
      198
    ],
    "last": [
      4
    ],
    "two": [
      5,
      88,
      186
    ],
    "decades": [
      6
    ],
    "have": [
      7,
      84,
      127
    ],
    "seen": [
      8
    ],
    "a": [
      9,
      21,
      32,
      39,
      141
    ],
    "very": [
      10
    ],
    "substantial": [
      11
    ],
    "rise": [
      12
    ],
    "in": [
      13,
      20,
      56,
      87,
      111,
      155,
      194
    ],
    "prevalence": [
      15
    ],
    "of": [
      16,
      23,
      42,
      60,
      72,
      135,
      140,
      143,
      149,
      173,
      197,
      201,
      209
    ],
    "heart": [
      17,
      122,
      207
    ],
    "failure,": [
      18,
      123
    ],
    "and": [
      19,
      31,
      62,
      100,
      107,
      119,
      154
    ],
    "majority": [
      22
    ],
    "patients": [
      24
    ],
    "hypertension": [
      25
    ],
    "is": [
      26,
      37,
      53
    ],
    "both": [
      27
    ],
    "an": [
      28,
      158
    ],
    "antecedent": [
      29
    ],
    "condition": [
      30
    ],
    "contributing": [
      33
    ],
    "cause.": [
      34
    ],
    "Heart": [
      35,
      104,
      115
    ],
    "failure": [
      36,
      208
    ],
    "also": [
      38,
      70,
      218
    ],
    "major": [
      40,
      89,
      187
    ],
    "cause": [
      41
    ],
    "hospital": [
      43
    ],
    "admissions;": [
      44
    ],
    "its": [
      45
    ],
    "amelioration": [
      46
    ],
    "and,": [
      47
    ],
    "as": [
      48,
      50,
      157
    ],
    "far": [
      49
    ],
    "possible,": [
      51
    ],
    "prevention": [
      52
    ],
    "therefore": [
      54
    ],
    "important": [
      55
    ],
    "terms": [
      57
    ],
    "not": [
      58
    ],
    "only": [
      59
    ],
    "morbidity": [
      61
    ],
    "premature": [
      63
    ],
    "mortality": [
      64
    ],
    "for": [
      65,
      170
    ],
    "individual": [
      67
    ],
    "patient,": [
      68
    ],
    "but": [
      69
    ],
    "containment": [
      71
    ],
    "healthcare": [
      73
    ],
    "costs.": [
      74
    ],
    "Over": [
      75
    ],
    "past": [
      77
    ],
    "5": [
      78
    ],
    "years,": [
      79
    ],
    "mineralocorticoid": [
      80
    ],
    "receptor": [
      81
    ],
    "(MR)": [
      82
    ],
    "antagonists": [
      83
    ],
    "been": [
      85
    ],
    "used": [
      86
    ],
    "outcome": [
      90,
      188
    ],
    "trials": [
      91
    ],
    "(the": [
      92
    ],
    "Randomized": [
      93
    ],
    "Aldactone": [
      94
    ],
    "Evaluation": [
      95
    ],
    "Study": [
      96,
      109
    ],
    "[RALES]": [
      97
    ],
    "with": [
      98
    ],
    "spironolactone,": [
      99
    ],
    "Eplerenone": [
      102
    ],
    "Post-AMI": [
      103
    ],
    "Failure": [
      105
    ],
    "Efficacy": [
      106
    ],
    "Survival": [
      108
    ],
    "[EPHESUS]),": [
      110
    ],
    "severe": [
      112
    ],
    "(New": [
      113
    ],
    "York": [
      114
    ],
    "Association": [
      116
    ],
    "class": [
      117
    ],
    "III)": [
      118
    ],
    "post-myocardial": [
      120
    ],
    "infarct": [
      121
    ],
    "respectively.": [
      124
    ],
    "Experimental": [
      125
    ],
    "studies": [
      126,
      145,
      189
    ],
    "largely": [
      128,
      213
    ],
    "focused,": [
      129
    ],
    "however,": [
      130
    ],
    "on": [
      131,
      137,
      146,
      214
    ],
    "various": [
      132
    ],
    "animal": [
      133
    ],
    "models": [
      134
    ],
    "hypertension;": [
      136
    ],
    "basis": [
      139
    ],
    "portfolio": [
      142
    ],
    "clinical": [
      144
    ],
    "efficacy": [
      148
    ],
    "eplerenone,": [
      150
    ],
    "administered": [
      151
    ],
    "either": [
      152
    ],
    "alone": [
      153
    ],
    "combination": [
      156
    ],
    "antihypertensive": [
      159
    ],
    "agent,": [
      160
    ],
    "novel": [
      162
    ],
    "MR": [
      163
    ],
    "antagonist": [
      164
    ],
    "was": [
      165
    ],
    "approved": [
      166
    ],
    "by": [
      167
    ],
    "FDA": [
      169
    ],
    "treatment": [
      172
    ],
    "hypertension,": [
      174
    ],
    "though": [
      175
    ],
    "it": [
      176
    ],
    "has": [
      177
    ],
    "yet": [
      178
    ],
    "to": [
      179,
      206
    ],
    "be": [
      180,
      219
    ],
    "launched.": [
      181
    ],
    "In": [
      182
    ],
    "this": [
      183
    ],
    "review,": [
      184
    ],
    "(RALES,": [
      190
    ],
    "EPHESUS)": [
      191
    ],
    "are": [
      192
    ],
    "discussed": [
      193
    ],
    "context": [
      196
    ],
    "new": [
      199
    ],
    "biology": [
      200
    ],
    "aldosterone": [
      202
    ],
    "action.": [
      203
    ],
    "The": [
      204
    ],
    "relevance": [
      205
    ],
    "current": [
      210
    ],
    "experimental": [
      211
    ],
    "studies,": [
      212
    ],
    "vascular": [
      215
    ],
    "protection,": [
      216
    ],
    "will": [
      217
    ],
    "discussed.Keywords11Î²-hydroxysteroid": [
      220
    ],
    "dehydrogenasealdosteroneheart": [
      221
    ],
    "failurehypertensionmineralocorticoid": [
      222
    ],
    "receptorreactive": [
      223
    ],
    "oxygen": [
      224
    ],
    "speciesredox": [
      225
    ],
    "statesaltvascular": [
      226
    ],
    "inflammation": [
      227
    ]
  },
  "abstract_inverted_index_v3": null,
  "cited_by_api_url": "https://api.openalex.org/works?filter=cites:W2166751652",
  "counts_by_year": [
    {
      "year": 2022,
      "cited_by_count": 1
    },
    {
      "year": 2015,
      "cited_by_count": 2
    },
    {
      "year": 2012,
      "cited_by_count": 1
    }
  ],
  "updated_date": "2025-05-16T03:59:59.647546",
  "created_date": "2016-06-24"
}